Bolt earnings beat by $1.27, revenue topped estimates

Bolt (BOLT) reported Q3 EPS of -$2.25, beating estimates by $1.27, with revenue of $450K, exceeding expectations of $426.25K. The stock is up 76.42% in 3 months and 29.32% in 12 months. InvestingPro rates Bolt's financial health as 'fair performance'.

Original reporting
Published Nov 13, 2026, 12:34 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 12:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BOLT
Bullish
medium confidence
Mentioned
$BOLT
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$BOLTBullishMed
01

Why it matters

The earnings surprise provides a short‑term catalyst, but the company's small market cap and ongoing losses temper long‑term expectations.

02

Market read

Earnings beat offers a brief trading opportunity for momentum‑focused traders.

03

What to watch

Liquidity constraints and the company's negative earnings may limit sustained upside.

Relevance 6/10Novelty 7/10Timing: post-market today

Background

Bolt is a micro‑cap listed on NASDAQ that recently posted a modest earnings beat.

Company-level read

Ticker impact

$BOLTBullishMedium confidence
Context

Bolt reported Q3 EPS of -$2.25 beating the estimate of -$3.52 and revenue of $450K versus $426.25K consensus.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The beat on both earnings and revenue, despite the company’s small size, provides a fresh catalyst that could attract traders looking for upside.

Market effects

Minimal; the micro‑cap tech niche may see slight attention but no broader sector shift.

Limited to U.S. small‑cap investors.

Low; the company’s size limits global impact.

Counterpoint

The beat may be a statistical fluke for a micro‑cap; price could revert quickly.

Key entities

  • Bolt

    NASDAQ‑listed micro‑cap reporting Q3 earnings.

Related articles

$BOLTHighAI 8/10

Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Bolt Biotherapeutics, Inc. (BOLT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update • Completed acquisition of Prana Therapies and $120 million concurrent private placement financing, establishing PRA-216 and the INSPIRE-built pipeline as Bolt’s primary de

$BOLTHigh

Bolt Biotherapeutics, Inc. (BOLT): Completion of Acquisition or Disposition of Assets

Bolt Biotherapeutics, Inc. (BOLT) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications • Transactions position the company to advance Prana’s pipeline of next-generation, half-lif